Home Tags Bayer

Tag: Bayer

Stamford’s Loxo Oncology receives FDA approval on cancer drug

"The approval of Vitrakvi is a testament to the relentless prioritization of biology in the drug development process," said Josh Bilenker, CEO of Loxo Oncology.

Loxo Oncology completes rolling submission of new drug application for larotrectinib

Stamford-based Loxo Oncology Inc has announced its completion of the rolling submission of a new drug application to the U.S. Food and Drug Administration for the TRK inhibitor treatment larotrectinib.

Stamford’s Loxo Oncology in multimillion-dollar cancer drug partnership with Bayer

Loxo Oncology will receive an upfront payment of $400 million and will be eligible for $450 million in milestone payments upon regulatory approvals.

Connecticut hospitals team with Bayer to reduce patients’ radiation risk

The pair have formed an alliance to establish the nation’s first-ever statewide radiation dose management repository.

Boehringer ridding itself of U.S. consumer health products; Ridgefield impact to...

Under the proposed swap, Boehringer will acquire Sanofi’s animal care subsidiary, while Sanofi will obtain Boehringer’s consumer health care business unit.

Eye drug drives eye-popping company growth

Regeneron Pharmaceuticals in Greenburgh reported more than doubling revenue in 2012, driven by $838 million in sales of its 1-year-old drug Eylea.

Bayer acquires Schiff for $1.2B

Tarrytown-based Bayer HealthCare L.L.C. announced on Tuesday that it has acquired Schiff Nutrition International for $1.2 billion.

GE ranks third on air pollution index

(Updated) UMass researchers ranked GE third on a list of the worst air polluters in the country.